Articles
Biosimilars Jumpstart Biotech in India
April 15, 2007 ( Gen. Eng. News, Vol.27, P.52)
http://www.genengnews.com/articles/chitem.aspx?aid=2099
ApoLife could sell for USD 50m, Abbott or Lilly preferred buyers, says President, January 17, 2007
Merger Market - Kimberly Ha in Singapore and Sasha Damouni in New York (link)
Company Update: ApoLife Touts Yeast-Based Expression System
Sep 15 2006 (Gen. Eng. News, Vol. 26, No. 16)
Company Cites Platform's Advantages from Discovery through Commercial Manufacturing
http://www.genengnews.com/articles/chitem.aspx?aid=1861
Development & Production of Antibodies
Aug 1 2006 (Gen. Eng. News, Vol. 26, No. 14)
Looking at the Needs and Challenges and Considering the Range of Possible Alternatives
http://www.genengnews.com/articles/chitem.aspx?aid=1832
Can India's IT Success be Replicated in Biotech?
Jun 15 2005 (Gen. Eng. News, Vol. 25, No. 12)
IP Regulations and Supportive Gov't Commitment for R&D Will Be the Key
http://www.genengnews.com/articles/chitem.aspx?aid=997
June 2, 2003 - Crain’s Detroit Business
Stroh offshoot brews up medical proteins using yeast
http://www.crainsdetroit.com/apps/pbcs.dll/article?AID=/20030602/SUB/306020905&SearchID=73243953430313
April 2, 1998 - The Detroit News Business Focus: Technology
Researcher seeks weapons against cancer. (link)
Protein Expression & Purification Volume 8, 1996, 447-455
Production, Purification & Characterization of Recombinant Human Hemoglobin Rainier Expressed in Saccharomyces cerevisiae.
Michigan Economic Development Corporation (MEDC) –
Life Science Company Profile- ApoLife, Inc,. (link)
Presentations
Antibodies and Beyond Antibodies:ApoLife President Dr. Motwani Chair:
Emerging Trends in Biotechnology:
IBC’s 4th Annual International Congress on Drug Discovery & Development of Innovative Therapeutics, India, October 10-12, 2007 in Hyderabad, India
ApoLife presented at CHI-PepTalk meeting in San Diego, Jan. 9-12, 2007
www.chi-peptalk.com
ApoLife presented at Bio Asia Meeting in Hyderabad, India, February 15-17, 2007
New Frontiers in Biotechnology-Novel technology for Antibody production
ApoLife presented at IBC BIOPHARM Asia Meeting, Singapore,December 12-14,2006
Developments in BioProcess Technology: New Strategies in Expression, Upstream and Downstream Processing
-A cost-effective system for screening and production of recombinant proteins using yeast (S.cerevisiae)
ApoLife presented at, IBC 16th International conference on Antibody Development & Production, SanDiego, CA February 27th – March 3rd, 2006
Screening and Production of Functional IgG, Antibody Fragments and Immunotoxins in Saccharomyces cerevisiae
http://www.bio.org/events/2006/poster/online/index.asp?lst=org
ApoLife presented at BIO 2005, Philadelphia,PA June 19-22
Antibody Production and Downstream Processing
High-level secretion of functional IgG, Fab and scFv antibody fragments and fusion proteins in Saccharomyces cerevisiae (link)
Awards
NIH-CAP Program 2005 – WWW.LARTA.ORG –
company selected in the NIH-CAP program
MEDC / MLSC Awards 2000 -2003 for ApoLife, Inc
Small Scale Production Services for Recombinant Protein
http://www.michigan.org/medc/cm/attach/F1BE7E0C-9CA5-4CAC-AA75-E3057475C686/2000_2003_MLSC%20Awards.pdf
SBIR Phase I & Phase II (NIH & NCI) - Fiscal year 1997-2001
http://grants2.nih.gov/grants/award/trends/congdist9701.txt |
